Atai Life Sciences N.V. (ATAI) recently reported positive topline results from Beckley Psytech's phase 2a open-label study of BPL-003 for the treatment of 12 patients with moderate-to-severe alcohol ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Atai Life Sciences and Beckley Psytech announced positive results from a Phase 2b clinical trial evaluating BPL-003, a treatment for treatment-resistant depression (TRD). The study achieved its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results